Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
526.17
+8.91 (1.72%)
May 26, 2026, 2:35 PM EDT - Market open
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of $12.13 billion as of May 26, 2026. Its market cap has increased by 82.39% in one year.
Market Cap
12.13B
Enterprise Value
11.52B
1-Year Change
82.39%
Ranking
Category
Stock Price
$526.17
Market Cap Chart
Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $12.13B, an increase of 3,977.71%. That is a compound annual growth rate of 21.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 11.93B | -9.83% |
| Dec 31, 2025 | 13.23B | 96.52% |
| Dec 31, 2024 | 6.73B | 47.33% |
| Dec 29, 2023 | 4.57B | -7.98% |
| Dec 30, 2022 | 4.96B | 242.65% |
| Dec 31, 2021 | 1.45B | -15.74% |
| Dec 31, 2020 | 1.72B | 22.31% |
| Dec 31, 2019 | 1.41B | -18.98% |
| Dec 31, 2018 | 1.74B | 51.27% |
| Dec 29, 2017 | 1.15B | 565.31% |
| Dec 30, 2016 | 172.40M | 255.46% |
| Dec 31, 2015 | 48.50M | -83.19% |
| Dec 31, 2014 | 288.60M | -20.30% |
| Dec 31, 2013 | 362.10M | -35.14% |
| Dec 31, 2012 | 558.30M | 141.48% |
| Dec 30, 2011 | 231.20M | -6.85% |
| Dec 31, 2010 | 248.20M | 44.39% |
| Dec 31, 2009 | 171.90M | -17.20% |
| Dec 31, 2008 | 207.60M | -8.55% |
| Dec 31, 2007 | 227.00M | -23.70% |
| Feb 6, 2007 | 297.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 15.05B |
| BridgeBio Pharma | 13.54B |
| Summit Therapeutics | 12.90B |
| Exelixis | 12.61B |
| Ionis Pharmaceuticals | 12.49B |
| Axsome Therapeutics | 12.14B |
| ABIVAX Société Anonyme | 10.68B |
| Arrowhead Pharmaceuticals | 10.56B |